Save your place

Sign in to WhoBought

Please try again later.

Akero Therapeutics, Inc. (AKRO) institutional ownership

Market cap$4.3B SectorHealthcare
Funds holding · Q1 2026
2
reported AKRO position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
0 buyers · 2 sellers

Akero Therapeutics, Inc. (AKRO) price and institutional activity

Dates

Q1 2026

$0 bought by 0 investors
$0 sold by 2 investors
DekaBank Deutsche GirozentraleIfp Advisors, Inc
Bought Sold Totals per quarter; hover a bar for the names.

Akero Therapeutics, Inc. (AKRO) institutional activity · 2

Investor Type Est. change Change Δ Own Date
DekaBank Deutsche Girozentrale · Exited
Change −20K Δ Own −100.0% Date Q1 2026
DekaBank Deutsche Girozentrale Exited· Q1 2026 −20K −100.0% Q1 2026
Ifp Advisors, Inc · Exited
Change −18 Δ Own −100.0% Date Q1 2026
Ifp Advisors, Inc Exited· Q1 2026 −18 −100.0% Q1 2026
Data through Q1 2026 · filed Q1 2026
2 of 2

Famous investor activity in Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics, Inc. (AKRO) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Judy Chou · Director 5 operations -91K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Judy Chou Director 5 operations -91K 0 Dec 9, 2025 Dec 9, 2025
Gangloff Scott A. · Officer 5 operations -322K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Gangloff Scott A. Officer 5 operations -322K 0 Dec 9, 2025 Dec 9, 2025
Heyman Tomas J. · Director 5 operations -78K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Heyman Tomas J. Director 5 operations -78K 0 Dec 9, 2025 Dec 9, 2025
Xu Yuan · Director 6 operations -104K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Xu Yuan Director 6 operations -104K 0 Dec 9, 2025 Dec 9, 2025
Cheng Andrew · Director, Officer 16 operations -2.1M
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Cheng Andrew Director, Officer 16 operations -2.1M 0 Dec 9, 2025 Dec 9, 2025
Harrison Seth Loring · Director 9 operations -402K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Harrison Seth Loring Director 9 operations -402K 0 Dec 9, 2025 Dec 9, 2025
Graham G. Walmsley · Director 4 operations -1.3M
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Graham G. Walmsley Director 4 operations -1.3M 0 Dec 9, 2025 Dec 9, 2025
Rolph Timothy · Officer 13 operations -688K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Rolph Timothy Officer 13 operations -688K 0 Dec 9, 2025 Dec 9, 2025
Iwicki Mark T. · Director 9 operations -250K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Iwicki Mark T. Director 9 operations -250K 0 Dec 9, 2025 Dec 9, 2025
White William Richard · Officer 18 operations -719K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
White William Richard Officer 18 operations -719K 0 Dec 9, 2025 Dec 9, 2025
Yale Catriona · Officer 11 operations -531K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Yale Catriona Officer 11 operations -531K 0 Dec 9, 2025 Dec 9, 2025
Lamy Patrick · Officer 8 operations -243K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Lamy Patrick Officer 8 operations -243K 0 Dec 9, 2025 Dec 9, 2025
Henderson Jane · Director 7 operations -103K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Henderson Jane Director 7 operations -103K 0 Dec 9, 2025 Dec 9, 2025
Young Jonathan · Officer 16 operations -772K
Owned 0 Trade date Dec 9, 2025 Filed date Dec 9, 2025
Young Jonathan Officer 16 operations -772K 0 Dec 9, 2025 Dec 9, 2025
Young Jonathan · Officer Gift (G) -9K
Owned 200K Trade date Nov 26, 2025 Filed date Nov 26, 2025
Young Jonathan Officer Gift (G) -9K 200K Nov 26, 2025 Nov 26, 2025
15 of 38
15 of 38 Sign in to continue to older insider transactions.

Akero Therapeutics, Inc. (AKRO) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Wellington Management Group LLP 7.9M
% of shares outstanding 11.4% Filing date Nov 8, 2024
Wellington Management Group LLP 7.9M 11.4% Nov 8, 2024
Janus Henderson Group PLC 7.1M
% of shares outstanding 10.2% Filing date Nov 14, 2024
Janus Henderson Group PLC 7.1M 10.2% Nov 14, 2024
Rtw Investments, LP 5.9M
% of shares outstanding 8.5% Filing date Nov 14, 2024
Rtw Investments, LP 5.9M 8.5% Nov 14, 2024
General Atlantic, L.P. 5.2M
% of shares outstanding 7.7% Filing date Mar 15, 2024
General Atlantic, L.P. 5.2M 7.7% Mar 15, 2024
BlackRock Inc. 4.2M
% of shares outstanding 7.5% Filing date Jan 26, 2024
BlackRock Inc. 4.2M 7.5% Jan 26, 2024
Vanguard Group Inc 3.1M
% of shares outstanding 5.5% Filing date Feb 13, 2024
Vanguard Group Inc 3.1M 5.5% Feb 13, 2024
T. Rowe Price Associates 3.8M
% of shares outstanding 5.5% Filing date Nov 14, 2024
T. Rowe Price Associates 3.8M 5.5% Nov 14, 2024
Alkeon Capital Management LLC 3.3M
% of shares outstanding 4.8% Filing date Nov 13, 2024
Alkeon Capital Management LLC 3.3M 4.8% Nov 13, 2024
8 of 18

Akero Therapeutics, Inc. (AKRO) ownership FAQ

Who owns AKRO?

2 reporting institutions disclosed AKRO position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.